Upadhyay Suketu
SEC insider (Form 3/4/5 filer). CIK 0001533149. EVP & Chief Financial Officer at INCYTE CORP (INCY) and 2 other issuers. 35 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in BOSTON, MA.
Companies Upadhyay Suketu has filed insider reports for
- INCYTE CORP (INCY): Officer, EVP & Chief Financial Officer
- VERTEX PHARMACEUTICALS INC / MA (VRTX): Director
- ZIMMER BIOMET HOLDINGS, INC. (ZBH): Officer, Exec VP, CFO
Upadhyay Suketu
CIK: 0001533149
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (35 total)
- May 4, 2026INCY
INCYTE CORP
AwardDirect26.3K shares- - May 1, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirectDeferred Stock Units
796 shares- - May 1, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirectStock Option (Right to Buy)
2.9K shares- - May 1, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
DispositionDirect796 shares- - Apr 15, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirectDeferred Stock Units
81 shares at avg. $442.50- - Mar 6, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
Tax PaymentDirect4.5K shares at avg. $92.54$421K - Mar 6, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
ExerciseDirect4.6K shares- - Mar 6, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
Tax PaymentDirect2K shares at avg. $92.54$188K - Mar 6, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
ExerciseDirect10.2K shares- - Feb 25, 2026ZBH
ZIMMER BIOMET HOLDINGS, INC.
ExerciseDirect6.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 | INCY INCYTE CORP | Award | 26,343 | - | $0 | Direct |
| May 1, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award Deferred Stock Units | 796 | - | - | Direct |
| May 1, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award Stock Option (Right to Buy) | 2,866 | - | - | Direct |
| May 1, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Disposition | 796 | - | $0 | Direct |
| Apr 15, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award Deferred Stock Units | 81 | $442.50 | - | Direct |
| Mar 6, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Tax Payment | 4,547 | $92.54 | $420,779 | Direct |
| Mar 6, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Exercise | 4,559 | - | $0 | Direct |
| Mar 6, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Tax Payment | 2,029 | $92.54 | $187,764 | Direct |
| Mar 6, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Exercise | 10,217 | - | $0 | Direct |
| Feb 25, 2026 | ZBH ZIMMER BIOMET HOLDINGS, INC. | Exercise | 6,364 | - | $0 | Direct |
1-10 of 35 transactions